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In management of patients with pyogenic vertebral osteomyelitis, organism isolation by biopsy is generally
considered to be of primary importance when constructing a treatment plan. In our clinical practice, however,
patients can be successfully treated even without identifying the organisms. The objective of this study is to review
our clinical experiences and clarify the therapeutic impact of organism isolation. Forty patients who were
conservatively managed in our institution constituted the base of this study. The average follow-up period was
16.7 months. Among the study subjects, 13 patients underwent percutaneous needle biopsy and the organism was
identified in 6 patients. Additionally, the organism was isolated from the sample obtained from blood and possible
foci in 10 patients. In total, the causative organism was identified in 15 of the 40 patients (37.5%). Patients were
divided into two groups based on whether the organism was identified by culture (Groups A and B, with and
without organism isolation respectively). The duration of antibiotic therapy was not significantly different between
the groups (Group A: 4.8 ± 1.6 months, Group B: 4.3 ± 2.1 months), while subsequent mortalities in Group A and B
were 13.3% and 8% without significant intergroup difference. Organism isolation did not productively help select
the effective antibiotics and reduce the treatment period or mortality rate in treatment of patients with pyogenic
vertebral osteomyelitis. Therefore, current strategic antibiotic therapy may be effective in eradicating infection even
without identification of the causative organism in treatment of patients with pyogenic vertebral osteomyelitis.
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In management of pyogenic vertebral osteomyelitis (PVO),
isolation of the causative organism is generally considered
to be a key to constitution of an effective treatment regi-
men. Therefore, a culture of the sample obtained from the
percutaneous spinal biopsy is primarily performed to find
out the antibiotics to which the identified organism is sen-
sitive (Currier et al. 2006; Grados et al. 2007; Mylona et al.
2008). In addition to the biopsied specimen, other samples
from blood and other possible foci are also subjected to
culturing to survey for the potential source of infection
(Carragee 1997; Weinberg and Silber 2004). Regarding the
significance of bacteriological examination of the biopsied
specimen, it has been reported that the frequency of
organism isolation by biopsy is consistently feasible and* Correspondence: tachi@hyo-med.ac.jp
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in any medium, provided the original work is phas a broad range in several studies (Currier et al. 2006;
Hadjipavlou et al. 2000, 2004; Lucio et al. 2000). If isola-
tion of organisms is necessary for PVO treatments, then
patients who did not have organisms isolated would have
poor prognosis; however, in our clinical practice, patients
with PVO can be successfully treated even without the
identification of organisms. Consequently, the significance
of percutaneous biopsy and acquisition of local tissue for a
culture seem questionable. Therefore, the objective of this
study is to review our clinical experiences and clarify the
therapeutic impact of organism isolation on the treatment
of patients with PVO.Methods
From 1996 to 2006, 68 patients with diagnosis of PVO
were selected as the primary study cohort based on our
clinical database. By reviewing the clinical record of each
of these 68 patients, 40 patients who did not receiveis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.






Pseudomonas aeruginosa 3 cases
Total 10 cases
MRSA: Methicillin resistant staphylococcus aureus, MSSA: Methicillin sensitive
staphylococcus aureus.
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constituted the base of this study population. Organism
identification was attempted by culture of blood and
samples obtained from the possible foci of infection in
those patients, while 13 of the 40 patients underwent
percutaneous needle biopsy.
Based on the culture results, the included patients
were divided into two groups: Group A (15 patients),
causative organisms were isolated; and Group B (25
patients), organisms were not identified. The mean age
for Group A was 62.1 years (range, 29–77 years), and
the follow-up period averaged 12.8 months (range, 2–
54 months). In this group of patients, the causative
organism and the source of the specimens revealing
positive culture were reviewed in the patient record. In
the remaining 25 Group B patients, the mean age and
follow-up period were 64.3 years (range, 15 – 84 years)
and 64.3 months (range, 2–91 months) respectively.
All the patients gave the informed consent prior being
included into the study. The study was authorized by the
local ethical committee, Hyogo College of Medicine and
was performed in accordance with the Ethical standards
of the 1964 Declaration of Helsinki as revised in 2000.
Based on the review of patient records, clinical parame-
ters such as affected spinal level, comorbidity, selection of
antibiotics, duration of antibiotic administration required
for subsidence of infection, and subsequent mortality were
compared between the groups.
In the statistical analysis, t-tests were performed with
Excel (Microsoft Corporation, Redmond, WA, USA) and
a Fischer’s exact test was performed using SPSS (SPSS,
Chicago, IL, USA). A p-value of < 0.05 was considered to
indicate significance.
Results
Among the 13 patients who underwent percutaneous
needle biopsy, organisms were identified in 7 patients
(53.8%). The organisms isolated from the spinal biopsy
samples are shown in Table 1. Potentially causative or-
ganisms were isolated from blood and other foci in 10
patients as shown in Table 2. In total, organisms were
identified in 15 patients (Group A); however, the antibi-
otics that were already administered at the correspond-




Pseudomonas aeruginosa 2 cases
Others 1 case
Total 7 cases
MSSA: Methicillin sensitive staphylococcus aureus.15 patients (93%). In other words, isolation of the or-
ganism induced a change in antibiotic selection in only
one of the 13 patients with positive culture results in
needle biopsy. Therefore, identification of the organism
could not provide a therapeutic benefit in a majority of
the patients. The total number of antibiotics given is
shown in Table 3. Antibiotic administration was start
with use of a single agent, while change to other agents
or use of multiple agents were considered depending on
sequential change in inflammatory reaction. In Group
A, There were cervical lesion in one patient, thoracic
lesions in 7 patients, and lumbar lesions in 7 patients;
while, In Group B, there were cervical lesions in 3
patients, thoracic in 7 patients, and lumber lesions in 18
patients. Comorbidities were malignant diseases in 5
patients, diabetes in 3 patients, autoimmune diseases in
2 patients, and other infectious lesions in 4 patients in
Group A; while for Group B there were malignant dis-
eases in 3 patients, diabetes in 9 patients, autoimmune
diseases in 3 patients, and other infectious lesions in 4
patients. There were no significant differences between
groups.
The duration of antibiotic administration required for
subsidence of infection was not significantly different
between the groups (4.8 ± 1.6 months in Group A and
4.3 ± 2.1 months in Group B; Table 4). SubsequentExtended spectrum penicillins
Plus beta lactamase inhibitor 5 6






Table 4 Duration of antibiotic therapy
Duration of antibiotic therapy
(months)
A (with isolation of organism) 4.8 ± 1.6
B (without isolation of organism) 4.3 ± 2.1
No significant difference between the groups.
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spectively with no intergroup difference (Table 5).
Discussion
In constituting a management plan for patients with PVO,
in general, a blood culture is initially performed because
the infection may be hematogenous in origin (Currier
et al. 2006; Grados et al. 2007). In the present study, other
infectious lesions such as pyogenic arthritis were concomi-
tantly present in 7 patients. In the other 33 patients, the
original focus of infection was unknown; however organ-
isms may have been known to spread to the spine hemato-
genously. When the blood culture fails to reveal the
potentially causative organisms, percutaneous biopsy can
be the next option to survey for this. In previous clinical
studies, the positive rate in a blood culture performed for
patients with PVO ranged from 55.6% to 59% (Carragee
1997; Weinberg and Silber 2004). In the present study,
however, culture of blood and samples obtained from pos-
sible foci demonstrated positive results in only 10 patients
(25%). By contrast, a culture of the needle biopsy sample
showed positive results in 53.8% of the patients. The rates
of positive culture results from needle biopsy have been
reported with variable values ranging from 30.4% to 86%
(Currier et al. 2006; Hadjipavlou et al. 2000; Sehn and
Gilula 2010), and the rates of sample acquisition by trans-
pedicular discectomy have been reported as well (range,
73.5% to 78%) (Hadjipavlou et al. 2004; Lucio et al. 2000).
Therefore, 14% to 69.6% of patients with PVO were
treated without isolating the causative organisms.
There has been only one study investigating the effect
of organism isolation on the enhancement of treatment
efficacy. In this report, Rankine et al. demonstrated that
the results of biopsy lead to change in management in 7
out of 20 patients (35%) (Rankine et al. 2004). In the
present study, isolation of the organism induced a change
in antibiotic selection for only 1 of the 13 patients with
positive culture results in needle biopsy, while isolation ofTable 5 Mortality of the patients
Survivors (n) Non-survivors (n) Mortality
rate
A (with isolation of
organism)
13 2 13.3%
B (without isolation of
organism)
23 2 8.0%
No significant difference between the groups.the organism from blood or other foci did not lead to a
change in antibiotic selection in any of the patients.
As for the duration of antibiotic therapy for patients
with PVO, administration for a relatively long time period
is generally recommended. Early cessation of antibiotics at
4 to 6 weeks has been reported to be associated with a
higher recurrence rate (Currier et al. 2006; Sapico and
Montgomerie 1979; Roblot et al. 2007), and thus adminis-
tration for more than 12 weeks is the general consensus
(Grados et al. 2007). The average time period of antibiotic
therapy (4.5 months) in this study corresponds to the
duration reported in previous studies. Regarding whether
isolation of organisms can help construct an effective
treatment protocol and reduce the treatment period, the
results of this study showed no difference in duration of
antibiotic therapy regardless of the status of organism
identification. The mortality rate in patients with PVO has
been reported to be relatively low ranging from less than
5% to 16% (Currier et al. 2006). The mortality rates in the
two groups of this study (8% in Group A and 13.3% in
Group B) correspond to those in previous studies, and iso-
lation of the organisms did not influence the mortality
rate. Comorbidities including malignant disease which
may influence the mortality rate were also not different
between groups. There has been no study investigating
the significance of percutaneous needle biopsy in treat-
ment of patients with PVO by comparing the outcome of
the patient populations with and without isolation of the
organism. In regards to the selection of antibiotics, since
methicillin sensitive staphylococcus aureus (MSSA) used
to be the most frequently identified organism, the agent
targeting this species such as cefazolin was conventionally
selected as an initial choice (Bhavan et al. 2010; Nather
et al. 2005). However, since methicillin resistant staphylo-
coccus aureus (MRSA) has emerged as a predominant
organism causing PVO, anti-MRSA antibiotics may be
currently added as an option before isolation of the or-
ganism (Bhavan et al. 2010). If these agents cannot con-
trol the infection, the switching of antibiotics to those
with a broad spectrum and effectiveness against gram
negative organisms can be considered (Weinberg and
Silber 2004). It is thought that this concept of current
antibiotic selection can effectively cope with PVO regard-
less if the causative organism is isolated.
This study has several limitations. First, the study was
based on a retrospective chart review and was not pro-
spectively designed. Therefore, treatment decision making
(indication of percutaneous biopsy as well as antibiotic
selection and duration of administration) was arbitrarily
determined by the responsible surgeon. Moreover, the
sample size was relatively small and the follow-up period
in some patients may not have been long enough to inves-
tigate the clinical outcome. Moreover, in the general popu-
lation, pathogen distribution may be different from the
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designed, multi-center clinical trial with consistent treat-
ment criteria is required to draw validated conclusions.
Conclusions
The present study has shown that organism isolation did
not productively help select the effective antibiotics and
reduce the treatment period or mortality rate in the treat-
ment of patients with PVO. Although the study results do
not contradict the clinical significance of needle biopsy for
this patient population, the current strategic antibiotic
therapy may be effective in eradicating infection even
without identifying the causative organism in the treat-
ment of patients with PVO.
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